20478 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
Pharmaceutical composition for the treatment of diminution of bone tissue
#302Pharmaceutical compositions for preventing glucocorticoid-induced skin thinning
#303USE OF BUFODIENOLIDES IN DIAGNOSING AND TREATING ESSENTIAL HYPERTENSION
#304Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate
#305Methods and compositions for stimulating reepithelialisation during wound healing
#306TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
#307FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca)
#308COMPOSITIONS AND TREATMENT REGIMES FOR REDUCING INFLAMMATION, END-ORGAN INJURY, AND/OR SYSTEMIC ENDOTOXEMIA
#309Progesterone receptor modulators for use in the therapy of uterine fibroids
#310Inhibitors of the renal outer medullary potassium channel
#311Fluocinolone formulations in a biodegradable polymer carrier
#312Therapeutic and method of use
#313PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#314Combinations of Oral Medicaments Bonded by a Wrapping
#315Milk-derived microvesicle compositions and related methods
#316Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
#317Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s)
#318Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof
#319Intrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating
#320Na/K-ATPase ligand and uses thereof in wound healing
#321Use of Bufodienolides in Diagnosing and Treating Essential Hypertension
#322Bufalin liposome, preparation method therefor and application thereof
#323Indolealkylamino-withasteroid conjugates and method of use
#324Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#325Compositions for alleviating inflammation and oxidative stress in a mammal
#326Hormone Normalization Therapy and Uses Therefor
#327COMPOSITIONS AND METHODS FOR TREATMENT OF RENAL DISEASE
#328Compositions and methods for inhibiting hair growth
#329Compositions and methods for inhibiting hair growth
#330Certain chemical entities, compositions, and methods
#331Reducing the reproductive capacity of mammals
#332SNS-595 and methods of using the same
#333DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#334METHODS AND COMPOSITIONS RELATED TO ACUTE RESPIRATORY DISTRESS SYNDROME
#335Pharmaceutical compositions of pimobendan
#336Palatable oral veterinary compositions
#337Pharmaceutical composition for emergency contraception
#338Method and compounds for inhibiting the MCM complex and their application in cancer treatment
#339Very low-dosed solid oral dosage forms for HRT
#340METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#341Therapeutic and method of use
#342Inhibitors of the renal outer medullary potassium channel
#34318-METHYL-6,7-METHYLENE-3-OXO-17-PREGN-4-ENE-21,17B-CARBOLACTONES, PHARMACEUTICAL PREPARATIONS COMPRISING SAID COMPOUNDS AND USE THEREOF IN THE TREATMENT OF ENDOMETRIOSIS
#344Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal
#345Method of diagnosing and therapeutically treating a patient for a traumatic brain injury
#346Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
#347Na/K-ATPase ligand
#348Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation which is useful for preventing and/or treating multiple sclerosis
#349CARDIAC GLYCOSIDES ARE POTENT INHIBITORS OF INTERFERON-BETA GENE EXPRESSION
#350USE OF ANDROGEN FOR DISEASE TREATMENT
#351TREATMENTS FOR MELANOMA
#352Combination treatments for melanoma
#353Aldosterone induced vascular elastin production
#354PHARMACEUTICAL COMPOSITION FOR USE AS A CONTRACEPTIVE
#355Compositions for treating neurological disorders
#356Methods for the treatment of fibromyalgia and chronic fatigue syndrome
#357Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#358Cardiac Glycosides for Treating Autoimmune Disease
#359Composition for elastin production
#360Acne vulgaris treatment regimen
#361Therapeutic Gestagens For The Treatment Of Premenstrual Dysphoric Disorder
#362Perhexiline for treating chronic heart failure
#363USE OF SPIRONOLACTONE-BASED COMPOSITION THAT EXHIBITS AN INHIBITORY ACTION ON T-LYMPHOCYTE ACTIVATION WHICH IS USEFULE FOR PREVENTING AND/OR TREATING MULTIPLE SCLEROSIS
#364EXTRACT OF AERIAL PARTS OF MACA RICH IN POLYPHENOLS AND COMPOSITION COMPRISING SAME
#365Methods and compositions for stimulating reepithelialisation during wound healing
#366LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT
#367LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT
#368Certain chemical entities, compositions, and methods
#369Indolealkylamino-withasteroid conjugates and method of use
#370Small-molecule inhibitors of the androgen receptor
#371Apoptosis signal-regulating kinase inhibitors
#372Apoptosis signal-regulating kinase inhibitors
#373METHOD FOR THE TREATMENT OF CANCER
#374METHOD FOR THE TREATMENT OF CANCER
#375Treating various disorders using TrkB agonists
#376STABILISED PARTICLES COMPRISING 5-METHYL-(6S)-TETRAHYDROFOLATE
#377Cucurbitane-triterpenoid compounds, pharmaceutical composition, use and preparation method thereof
#378COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH
#379Neuroprotection and myelin repair using Nestorone®
#380DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#381MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS
#382Deoxycorticosterone induced elastin production
#383Compound having neurite-outgrowing activity
#384Sterol derivative
#385Pharmaceutical composition for emergency contraception
#386Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#387Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
#388RECEPTOR ACTIVATOR OF THE RANK RECEPTOR COMPLEX INHIBITOR
#389Perhexiline for treating chronic heart failure
#390Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains
#391COMPOSITIONS AND TREATMENT REGIMES FOR REDUCING INFLAMMATION, END-ORGAN INJURY, AND/OR SYSTEMIC ENDOTOXEMIA
#392Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of use
#393MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#394Therapeutic Gestagens for the Treatment of Premenstrual Dysphoric Disorder
#395TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION
#396Methods for treating sexual dysfunction while decreasing cardiovascular risk
#397Method of diagnosing and therapeutically treating a patient for a traumatic brain injury
#398Acne vulgaris treatment regimen
#399SNS-595 and methods of using the same
#400CARDENOLIDES FOR THE TREATMENT OF OCULAR CANCER
#401Na/K-Atpase Expression as an Indicator for the Treatment of Cancer
#402Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
#403Very low-dosed solid oral dosage forms for HRT
#404SNS-595 AND METHODS OF USING THE SAME
#405Methods of alleviating the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
#406WITHAFERIN A ANALOGS AND USES THEREOF
#407Small-molecule inhibitors of the androgen receptor
#408Medication and treatment for disease
#409INTRAVAGINAL DELIVERY SYSTEM AND PROCESS FOR MANUFACTURING IT
#410Certain chemical entities, compositions, and methods
#411Ursolic acid derivative and pharmaceutical composition thereof
#412Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs
#413METHOD FOR TREATING THE HYPERPIGMENTATION OF PATHOLOGICAL SCARS
#414Aldosterone induced vascular elastin production
#415Neurotrophic activity of deoxygedunin
#416Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
#417Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders
#418METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#419Combination of Oral Medicaments Bonded by a Wrapping
#420Apoptosis signal-regulating kinase inhibitors
#421MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS
#422Therapeutic Molecules and Methods-1
#423VAGINAL DELIVERY SYSTEM
#424COMPOSITIONS AND METHODS FOR TREATMENT OF RENAL DISEASE
#425NEW COMBINATIONS
#426Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
#427COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS
#428Method for the asymmetric synthesis of beta-lactone compounds
#429PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#430Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
#431PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
#432STEROID MODULATORS OF GLUCOCORTICOID RECEPTOR
#433DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#434Micronized Eplerenone Compositions
#435SEQUENTIAL SPRM/ PROGESTIN TREATMENT
#436Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action
#437ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES
#438Methods of inhibiting osteoclast activity
#439Combination therapy comprising diaryl ureas for treating diseases
#440COMPOSITIONS AND TREATMENTS OF HEART FAILURE IN NON-HUMAN MAMMAL ANIMALS
#441Fluocinolone formulations in a biodegradable polymer carrier
#442METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR
#443Na/K-ATPase ligand
#444Use of Digitalis-Like Compounds in the Treatment of Affective Disorders
#445Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition
#446DROSPIRENONE CONTAINING TRANSDERMAL DRUG DELIVERY DEVICES AND METHODS OF DELIVERY THEREOF
#447Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament
#448VAGINAL DELIVERY SYSTEM
#449COMPOSITIONS COMPRISING HYDROQUINONE, FLUOCINOLONE ACETONIDE AND TRETINOIN FOR TREATING PHOTOAGING OF THE SKIN
#450Combination of gestagen and insulin sensitizer for treating PCOS
#451DERMATOLOGICAL COMPOSITIONS COMPRISING HYDROQUINONE, FLUOCINOLONE ACETONIDE AND TRETINOIN FOR TREATING THE HYPERPIGMENTATION OF PATHOLOGICAL SCARS
#452Anti Mineralocorticoid Therapy of Infection
#453Aldosterone induced elastin production
#454NEW DROSPIRENONE/17BETA-ESTRADIOL REGIMEN, PHARMACEUTICAL COMBINATION PRODUCT AND KIT FOR PERFORMING THIS REGIMEN
#455Treating skin hyperpigmentation with dermatological compositions comprising hydroquinone, fluocinolone acetonide and tretinoin
#456Extended Use Combination Comprising Estrogens And Progestins
#457Combination Treatment for Enhancing Diuresis
#458PHARMACEUTICAL COMPOSITION COMPRISING PROGESTOGENS AND/OR ESTROGENS AND 5-METHYL-(6S)-TETRAHYDROFOLATE
#459METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS
#460Combination Therapy For Treating Heart Disease
#461Spironolactone nanoparticles, compositions and methods related thereto
#462Fast dissolving orally consumable films
#463Perhexiline For Treating Chronic Heart Failure
#464SALT SENSITIVITY AND PREVENTION OF HYPERTENSION WITH DROSPIRENONE
#465Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
#466Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications
#467Micronized Eplerenone Compositions
#468Withacnistin compounds for treatment of cancer
#469Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
#470Combination of organic compounds
#471Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors
#472Compositions of estrogen-cyclodextrin complexes
#473Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
#474Method of treating human volume expansion mediated hypertension employing resibufogenin
#47517-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
#476Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
#477Method for the asymmetric synthesis of beta-lactone compounds
#478Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#479Methods of cardioprotection using dichloroacetate in combination with an inotrope
#480Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
#481Therapeutic molecules and methods-1
#482Combination therapy for treating heart disease
#483Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors
#484Method for treatment of dysmenorrhea
#485Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
#486Topical nanoparticulate spironolactone formulation
#487SNS-595 and methods of using the same
#488Use of an aldosterone receptor antagonist to improve cognitive function
#489Pharmaceutical composition for use as a contraceptive
#490SNS-595 and methods of using the same
#491Regulators of the hedgehog pathway, compositions and uses related thereto
#492Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
#493Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
#494Management of breakthrough bleeding in extended hormonal contraceptive regimens
#495Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
#496Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#497Sequential SPRM/ progestin treatment
#498Stabilised supersaturated solids of lipophilic drugs
#499Methods of using SNS-595
#500Aldosterone antagonist compositions for release during aldosterone acrophase
#501Compositions of estrogen-cyclodextrin complexes
#502Menstrual cycle control and improvement of conception rates in females
#503Use of small molecule compounds for immunopotentiation
#504Composition
#505Methods of inhibiting osteoclast activity
#506Storage stable eplerenone formulation
#507Combination of an aldosterone receptor antagonist and an anti-diabetic agent
#508Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds
#509Compositions and methods for immune health
#510Spironolactone aqueous compositions
#511Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
#512Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients